Search results
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. -...
CW39 NewsFix· 1 hour agoPomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA). Such investors are advised to ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 4 days agoEarlier in the year, one analyst called results from the cancer vaccine study "transformational."...
COVID summer wave grows, especially in West, with new variant LB.1 on the rise
CBS News· 3 days agoA summertime wave of COVID-19 infections is arriving earlier than last year across a growing share...
FDA advises vaccine manufacturers to make COVID-19 booster targeting KP.2 strain
ABC Action News Tampa Bay· 11 hours agoThe FDA has issued an updated recommendation for the fall COVID-19 vaccine formula. "Coverage in the...
25,274 Shares in Moderna, Inc. (NASDAQ:MRNA) Bought by Los Angeles Capital Management LLC
ETF DAILY NEWS· 3 days agoLos Angeles Capital Management LLC acquired a new position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) during the 1st quarter, according to its most recent 13F ...
GAMMA Investing LLC Purchases 822 Shares of Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 5 days agoGAMMA Investing LLC grew its position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 37.8% in the first quarter, HoldingsChannel reports. The fund owned 2,994 shares ...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
Los Angeles Times· 6 days agoRasmussen Reports used to be a fairly creditable and credible political polling organization, good...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 3 days agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 4 days agoIts revenues have jumped from $28.3 billion in 2021 to $34.1 billion in 2023. Conclusion While other...
Gateway - Quartz
Quartz· 6 days agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1 bird flu vaccine, as the virus continues to spread rapidly ...